🟠 Moderate Evidence
A pooled analysis of 3,415 patients with acute ischemic stroke caused by large vessel occlusion (LVO) reveals that post-stroke acute heart failure (PSHF) develops in roughly 1 in 12 patients treated with endovascular thrombectomy and substantially worsens prognosis. According to research published in PLOS Medicine by investigators including Dr. Wenjie Zi and Dr. Chang Liu of Xuanwu Hospital Capital Medical University (Beijing), patients who developed PSHF faced a tripled odds of very poor functional outcome at 90 days, even after adjusting for stroke severity and other clinical factors.
Key takeaways
- Post-stroke acute heart failure occurred in 278 of 3,415 patients (8.14%) with large vessel occlusion treated by endovascular thrombectomy between 2014 and 2023
- Patients with PSHF had 62.23% rate of very poor functional outcome versus 31.08% in those without PSHF (adjusted odds ratio 3.09)
- Heart failure peaked at 1 day after stroke onset, suggesting acute cardiac stress from stroke-related neurological injury
- Cardioembolic stroke—where a blood clot originates from the heart—significantly modified the relationship between stroke severity and heart failure risk
Study at a Glance
| Source | PLOS Medicine |
| Study type | Pooled analysis of individual patient data from four prospective multicenter studies |
| Sample size | N = 3,415 patients with large vessel occlusion stroke |
| Population | Adults with acute ischemic stroke and large vessel occlusion undergoing endovascular thrombectomy |
| Country | China (multicentre, 2014–2023) |
Post-stroke acute heart failure and functional outcomes at 90 days
Comparison of very poor functional outcome (modified Rankin Scale 5–6) in patients with and without PSHF
Source: Chen et al., PLOS Medicine, 2024 | Georgian Medical Journal News
Cardiac complications rival stroke severity as outcome predictor
Stroke carries well-established risks of death and disability through direct neurological injury, but emerging evidence highlights that cardiac complications independently worsen prognosis. According to the PLOS Medicine analysis led by researchers from Xuanwu Hospital and collaborating Chinese stroke centres, the development of acute heart failure after stroke ranks as a major contributor to poor functional outcomes. The pooled cohort, drawn from four prospective multicenter studies conducted between January 2014 and June 2023, provided sufficient statistical power to examine both the frequency and prognostic impact of PSHF in the modern era of endovascular thrombectomy.
The incidence of PSHF—defined as new or worsening heart failure diagnosed during acute hospitalisation—peaked at 1 day after stroke onset, suggesting acute physiological stress rather than pre-existing disease. This temporal pattern indicates that the stroke itself, through mechanisms such as catecholamine release or direct neurogenic cardiac injury, triggers cardiac dysfunction in vulnerable patients. Understanding this relationship may improve risk stratification and enable earlier cardiac monitoring in high-risk patients. Clinical Updates on acute stroke management increasingly emphasize routine echocardiography or cardiac biomarker testing in the immediate post-stroke period.
Cardioembolic stroke fundamentally alters the stroke severity–heart failure relationship
Among patients with stroke caused by cardioembolic sources—blood clots that originate in the heart itself—the relationship between initial stroke severity and subsequent heart failure development differed significantly from other stroke subtypes. According to the PLOS Medicine study, mediation analysis revealed that PSHF partially explained how stroke severity influenced final functional outcome, particularly in cardioembolic cases. This finding suggests that in patients whose stroke originated from cardiac pathology, the underlying cardiac disorder not only triggered the stroke but also increased susceptibility to acute decompensation during the acute stroke phase.
The study adjusted for multiple clinically relevant confounders—demographic characteristics, vascular risk factors, baseline National Institutes of Health Stroke Scale (NIHSS) score, imaging features, and treatment factors—to isolate the independent contribution of PSHF. This methodological rigor strengthens the causal inference. Clinicians managing cardioembolic stroke may benefit from more aggressive cardiac assessment and monitoring, particularly when baseline stroke severity is high. Health Policy discussions around optimal acute stroke protocols should incorporate cardiac risk stratification at admission.
Endovascular thrombectomy safety profile unchanged; cardiac monitoring gains urgency
The study does not suggest that endovascular thrombectomy (EVT) itself causes PSHF; rather, PSHF emerges as a complication in the acute period following both stroke and reperfusion therapy. The PLOS Medicine analysis included 3,415 consecutive patients who underwent EVT, meaning these findings reflect real-world outcomes of modern thrombectomy practice. The identification of PSHF as an independent risk factor for poor outcome underscores the importance of comprehensive post-stroke monitoring that extends beyond neurological assessment.
Given that very poor functional outcome was defined as modified Rankin Scale (mRS) 5–6—corresponding to severe disability or death—the clinical stakes of PSHF prevention are high. Future research should examine whether early cardiac interventions, such as optimized fluid management, vasopressor strategies, or advanced heart failure therapies, can mitigate the prognostic impact of post-stroke cardiac dysfunction. These findings align with broader recognition that stroke and cardiac disease share common pathophysiology and that integrated cardiac–neurological care may improve long-term recovery.
Post-stroke acute heart failure increased the adjusted odds of very poor functional outcome (modified Rankin Scale 5–6) at 90 days by 3.09-fold (95% CI [2.25, 4.24]) compared to patients without PSHF, independent of baseline stroke severity and other clinical covariates.
— Dr. Wenjie Zi and Dr. Chang Liu, Xuanwu Hospital Capital Medical University; corresponding analysis (PLOS Medicine, 2024)
What this means
Frequently asked questions
What is post-stroke acute heart failure, and how is it different from chronic heart disease?
Post-stroke acute heart failure refers to new or acutely worsening heart function that develops during hospitalisation for acute stroke, typically within days of symptom onset. Unlike chronic heart disease, which develops gradually over years, PSHF is triggered by the acute stress of stroke—including catecholamine surge, inflammation, and neurogenic cardiac injury—and may resolve or improve as the patient recovers from stroke. According to the PLOS Medicine study, PSHF peaked at 1 day after stroke, reflecting this acute time course.
Why does cardioembolic stroke carry higher risk of heart failure than other stroke types?
Cardioembolic stroke occurs when a blood clot originates within the heart itself—often from atrial fibrillation, valvular disease, or cardiomyopathy. Patients with cardioembolic stroke therefore have pre-existing cardiac pathology that predisposes them to acute decompensation during the physiological stress of acute stroke. The PLOS Medicine analysis found that the relationship between stroke severity and PSHF was significantly modified by cardioembolic etiology, suggesting that underlying cardiac disease amplifies the stroke-induced cardiac stress response.
Can endovascular thrombectomy prevent post-stroke heart failure?
This study does not suggest that endovascular thrombectomy causes or prevents PSHF; rather, PSHF emerges as a complication in some patients regardless of reperfusion success. The 8.14% incidence observed across 3,415 patients reflects the baseline risk in the acute stroke population undergoing thrombectomy. Future trials may test whether specific fluid management strategies, cardiac medications, or monitoring protocols can reduce PSHF incidence or severity. Current evidence supports prompt reperfusion to minimize overall stroke burden, which may indirectly limit cardiac complications, but dedicated cardiac-focused interventions remain an active area of investigation.
The identification of post-stroke acute heart failure as a potent independent predictor of poor outcome reshapes clinical priorities in acute stroke care. Clinicians and hospital administrators should revisit acute stroke protocols to ensure systematic cardiac assessment and close monitoring during the critical first 48–72 hours post-admission. Multi-disciplinary stroke teams that integrate cardiology expertise from the outset may unlock opportunities to prevent progression to severe heart failure and improve patient recovery trajectories. As endovascular thrombectomy becomes standard of care for large vessel occlusion, recognizing and managing cardiac complications will be essential to translating mechanical reperfusion success into durable functional recovery.
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
